Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients

Nephrology Dialysis Transplantation

Volumn 16, Issue 2, 2001, Pages 307-312

  Jungers, Paul ^a   Choukroun, Gabriel ^a   Oualim, Zouhir ^a   Robino, Christophe ^a   Nguyen, Anh Thu ^a   Man, Nguyen Khoa ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Chronic renal failure; Predialysis; Progression; Recombinant erythropoietin; Retardation of dialysis

Indexed keywords

CREATININE; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; HEMOGLOBIN; IRON; PYRIDOXINE; RECOMBINANT ERYTHROPOIETIN; THIAMINE;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; CLINICAL OBSERVATION; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; SUPPLEMENTATION; TREATMENT OUTCOME;

EID: 0035146507     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.2.307     Document Type: Article

References (20)

1. Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass
2. Effect of recombinant human erythropoietin on renal function in humans
3. Subcutaneous erythropoietin administration in predialysis patients: A single centre prospective study
4. The use of epoetin beta in anemic predialysis patients with chronic renal failure
5. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients
6. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients
7. Cardiovascular effects of recombinant human erythropoietin in predialysis patients
8. Anemia ameliorates progressive renal injury in experimental DOCA-salt hypertension
9. The impact of early normalization of haematocrit by erythropoietin on renal damage in the remnant kidney model
10. Prevention of accelerated progression of renal failure induced by recombinant human erythropoietin in the rat remnant kidney
11. The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: A double-blind, placebo-controlled trial
12. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure
13. Blood pressure, left ventricular hypertrophy and long-term prognosis in haemodialysis patients
14. Renal function in predialysis children with chronic renal failure treated with erythropoietin
15. Folic acid supplementation improves erythropoietin response
16. Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients
17. Progression rate to end-stage renal failure in non-diabetic kidney diseases: A multivariate analysis of determinant factors
18. Hypoxia-induced changes in extracellular matrix metabolism in renal cells
19. Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta 1-independent mechanism
20. Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?